---
figid: PMC7003657__FBA2-2-126-g006
figlink: pmc/articles/PMC7003657/figure/fba21109-fig-0006/
number: Figure 6
caption: Schematic diagram of the consequences of TNFR2‐mediated survival signaling
  in ccRCC‐CD133+CSCs; selective ligation of TNFR2 mediates the induction of pSTAT3Ser727
  through phosphorylation of VEGFR2/PI 3K/Akt/mTORC pathway leading to the survival
  of CSCs in ccRCC. Pharmacological inhibition of these phosphorylated kinases results
  in a diminished expression of TNF‐mediated pSTAT3Ser727 formation and causes an
  increase in cell death. Furthermore, selective ligation of TNFR2 mediates the expression
  of TNFR2 and its association with pSTAT3Ser727 in mitochondria. The absence of TNFR2/STAT3
  causes an increase in cell death triggering change in mitochondrial ultrastructure,
  translocation of cytochrome c to cytosol, activation of cleaved caspase 3p175, phosphorylation
  of MLKLSer358, and generation of ROS, which can be blocked by NAC. Cell death is
  partially inhibited by z‐VAD.fmk, further attenuated by Nec‐1, with an additive
  effect by a combination of both z‐VAD.fmk and Nec‐1, indicating the dominance of
  necroptotic cell death pathway
pmcid: PMC7003657
papertitle: Tumor necrosis factor receptor‐2 signaling pathways promote survival of
  cancer stem‐like CD133+ cells in clear cell renal carcinoma.
reftext: John R. Bradley, et al. FASEB Bioadv. 2020 Feb;2(2):126-144.
pmc_ranked_result_index: '22406'
pathway_score: 0.9287907
filename: FBA2-2-126-g006.jpg
figtitle: Tumor necrosis factor receptor‐2 signaling pathways promote survival of
  cancer stem‐like CD133+ cells in clear cell renal carcinoma
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7003657__FBA2-2-126-g006.html
  '@type': Dataset
  description: Schematic diagram of the consequences of TNFR2‐mediated survival signaling
    in ccRCC‐CD133+CSCs; selective ligation of TNFR2 mediates the induction of pSTAT3Ser727
    through phosphorylation of VEGFR2/PI 3K/Akt/mTORC pathway leading to the survival
    of CSCs in ccRCC. Pharmacological inhibition of these phosphorylated kinases results
    in a diminished expression of TNF‐mediated pSTAT3Ser727 formation and causes an
    increase in cell death. Furthermore, selective ligation of TNFR2 mediates the
    expression of TNFR2 and its association with pSTAT3Ser727 in mitochondria. The
    absence of TNFR2/STAT3 causes an increase in cell death triggering change in mitochondrial
    ultrastructure, translocation of cytochrome c to cytosol, activation of cleaved
    caspase 3p175, phosphorylation of MLKLSer358, and generation of ROS, which can
    be blocked by NAC. Cell death is partially inhibited by z‐VAD.fmk, further attenuated
    by Nec‐1, with an additive effect by a combination of both z‐VAD.fmk and Nec‐1,
    indicating the dominance of necroptotic cell death pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF1B
  - AKT2
  - AKT3
  - AKT1
  - FEZF2
  - NLRP1
  - FCER2
  - PCSK1
  - CASP1
  - CASP2
  - CASP8
  - CASP9
  - CASP14
  - CASP12
  - CASP3
  - CASP4
  - CASP5
  - CASP6
  - CASP7
  - CASP10
  - N-Acetyl Cysteine
  - NAC
  - Mitochondrial damage
genes:
- word: TNFR2/pSTAT38er727
  symbol: TNFR2
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF1B
  entrez: '7133'
- word: DVEGFR2/PI-3K/Akt/MTORC
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: DVEGFR2/PI-3K/Akt/MTORC
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: DVEGFR2/PI-3K/Akt/MTORC
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: DVEGFR2/PI-3K/Akt/MTORCpathway
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: DVEGFR2/PI-3K/Akt/MTORCpathway
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: DVEGFR2/PI-3K/Akt/MTORCpathway
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Tof
  symbol: TOF
  source: hgnc_alias_symbol
  hgnc_symbol: FEZF2
  entrez: '55079'
- word: (NAC)
  symbol: NAC
  source: hgnc_alias_symbol
  hgnc_symbol: NLRP1
  entrez: '22861'
- word: fcell
  symbol: FCE2
  source: hgnc_prev_symbol
  hgnc_symbol: FCER2
  entrez: '2208'
- word: Nec-1
  symbol: NEC1
  source: hgnc_prev_symbol
  hgnc_symbol: PCSK1
  entrez: '5122'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
chemicals:
- word: N-Acetyl Cysteine
  source: MESH
  identifier: D000111
- word: NAC
  source: MESH
  identifier: C086501
diseases:
- word: Mitochondrial damage
  source: MESH
  identifier: D028361
---
